Mexican Regulatory Affairs Consulting Firm

SIMPLIFY YOUR MARKET APPROVAL

Medical Devices | Cosmetics | Dietary Supplements

The Mexican market is complex and diverse, so it's essential to have a tailored strategy for each product.

IPS is a leading provider of regulatory services for the health industries in Mexico. We help manufacturers and distributors of medical devices, dietary supplements, and cosmetics navigate the complex Mexican regulatory landscape. Contact us today to learn more.

 

IPSNews

Featured
Prórroga de la Manifestación de Valor Electrónica
IPS, Regulatory Framework, Logistics
Prórroga de la Manifestación de Valor Electrónica
IPS, Regulatory Framework, Logistics

El pasado 02 de junio de 2026, el Servicio de Administración Tributaria (SAT) dio a conocer la versión anticipada de la segunda resolución de modificaciones a las Reglas Generales de Comercio Exterior (RGCE) para el presente ejercicio. En dicha publicación, se establece formalmente la extensión del plazo de obligatoriedad para transmitir la Manifestación de Valor electrónica (MVe) hasta el 31 de julio de 2026.

IPS, Regulatory Framework, Logistics
RAUpdate: Prohibition of Erythrosine (Red 3 FD&C) in the Mexican Food Industry
IPS, Regulatory Framework, COFEPRIS, Dietary Supplements
RAUpdate: Prohibition of Erythrosine (Red 3 FD&C) in the Mexican Food Industry
IPS, Regulatory Framework, COFEPRIS, Dietary Supplements

The Mexican Ministry of Health (Secretaría de Salud) has issued an Agreement to eliminate the use of the coloring agent Erythrosine and its lakes (Red 3 FD&C) in food, beverages, and dietary supplements. This measure responds to a risk analysis that determined that the population's exposure exceeds internationally established safety limits.

IPS, Regulatory Framework, COFEPRIS, Dietary Supplements
RAUpdate New NOM-137-SSA1-2025: Requirements for Medical Device labeling in Mexico
IPS, Regulatory Framework, Medical Devices, COFEPRIS, Post market surveillance
RAUpdate New NOM-137-SSA1-2025: Requirements for Medical Device labeling in Mexico
IPS, Regulatory Framework, Medical Devices, COFEPRIS, Post market surveillance

On May 19, 2026, Mexico's Ministry of Health published the new NOM-137-SSA1-2025 in the Official Gazette of the Federation (DOF), which completely replaces the version in force since 2008.

IPS, Regulatory Framework, Medical Devices, COFEPRIS, Post market surveillance

Upcoming Events

Featured
ADLM 2026
Jul 26
Convention Center Anaheim
ADLM 2026
Convention Center Anaheim
Convention Center Anaheim
EXPO SPA
Jul 29
World Trade Center
EXPO SPA
World Trade Center
World Trade Center
EXPO MED
Aug 18
Centro Banamex
EXPO MED
Centro Banamex
Centro Banamex

Regulatory VAR

  • Dispositivos Médicos

  • Logística

  • Cosméticos

  • Aseguramiento de la Calidad

  • Tecnovigilancia

  • Suplementos Alimenticios

  • Publicidad

  • Inteligencia de Mercado

Explore the plays